Background illustration for clinical trials search

Paid Clinical Trials Norwalk

Discover 1,134 paid clinical trials in Norwalk, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: New Haven CT, Mineola NY, New York NY, Brooklyn NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07258511

Phase 3, Recruiting

A Study of GEN1106 in Participants With Solid Tumors

for
Solid Tumors, Urothelial Carcinoma
Location: New Haven CT, Lake Success NY, Myrtle Beach SC,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT07416123

Phase 1, Recruiting

A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, Boston MA, Baltimore MD, Milwaukee WI,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07226349

Phase 1, Recruiting

IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: New Haven CT, New York NY, Hackensack NJ, Summit NJ,
Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT07104032

Phase 3, Recruiting

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: New Haven CT, Boston MA, Grand Rapids MI,
Sponsor: Ottimo Pharma Limited

Sex: All

Age: 18+

Code: NCT07266428

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Study of YL205 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: New Haven CT, Louisville KY, Denver CO, Nashville TX,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06459973

Phase 1, Phase 2, Recruiting

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: New Haven CT, New York NY, Boston MA, Baltimore MD,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07349537

Phase 1, Recruiting

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

for
Breast Cancer, Advanced Solid Tumor
Location: New Haven CT, Birmingham AL, St Louis MO, Houston TX,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07222267

Phase 1, Recruiting

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

for
Squamous Cell Carcinoma of Head and Neck
Location: New Haven CT, Mineola NY, The Bronx NY, New York NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07276399

Phase 3, Recruiting

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Cleveland OH, Durham NC,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06859762

Phase 1, Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: New Haven CT, New York NY, Philadelphia PA, Fairfax VA,
Sponsor: EvolveImmune United, Inc

Sex: All

Age: 18+

Code: NCT07217171

Phase 1, Recruiting

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Toronto, San Antonio TX
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18+

Code: NCT07166601

Phase 1, Recruiting

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: New Haven CT, New York NY, Hackensack NJ,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT07080242

Phase 1, Recruiting

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

for
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency),
Location: New Haven CT, New York NY, Houston TX, Sacramento CA
Sponsor: Duke Street Bio Ltd

Sex: All

Age: 18+

Code: NCT06458712

Phase 1, Recruiting

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

for
Prostate Cancer Metastatic
Location: New Haven CT, The Bronx NY, Morristown NJ, Baltimore MD,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136624

Phase 3, Recruiting

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

for
Cervical Squamous Cell Carcinoma,
Location: New Haven CT, Hackensack NJ, Fairfax VA, Louisville KY,
Sponsor: Alentis Therapeutics AG

Sex: All

Age: 18+

Code: NCT07169734

Phase 1, Phase 2, Recruiting

A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

for
Advanced Solid Tumors
Location: New Haven CT, Hinsdale IL, Houston TX, Scottsdale AZ,
Sponsor: Sun Pharma Advanced Research Company Limited

Sex: All

Age: 18+

Code: NCT07042100

Phase 1, Recruiting

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Advanced Breast Cancer
Location: New Haven CT, Boston MA, Fairfax VA, Huntersville NC,
Sponsor: Ensem Therapeutics

Sex: All

Age: 18+

Code: NCT06993844

Phase 1, Phase 2, Recruiting

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

for
CTCL
Location: New Haven CT, Boston MA, Rochester NY, Richmond VA,
Sponsor: Prescient Therapeutics, Ltd.

Sex: All

Age: 18+

Code: NCT06854653

Phase 2, Recruiting

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

for
Familial Adenomatous Polyposis (FAP)
Location: New Haven CT, Boston MA, Danville PA, Baltimore MD,
Sponsor: Rapamycin Holdings Inc.

Sex: All

Age: 18+

Code: NCT06950385

Phase 3, Recruiting